Compounds > n-(3-ethoxycarbonyloxirane-2-carbonyl)-isoleucyl-proline
Page last updated: 2024-09-03

n-(3-ethoxycarbonyloxirane-2-carbonyl)-isoleucyl-proline and Age-Related Osteoporosis

n-(3-ethoxycarbonyloxirane-2-carbonyl)-isoleucyl-proline has been researched along with Age-Related Osteoporosis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Katunuma, N1

Reviews

1 review(s) available for n-(3-ethoxycarbonyloxirane-2-carbonyl)-isoleucyl-proline and Age-Related Osteoporosis

ArticleYear
[Structure-based drug development and medical/biological application of cathepsin specific inhibitors].
    Seikagaku. The Journal of Japanese Biochemical Society, 2009, Volume: 81, Issue:11

    Topics: Antigen Presentation; Autoantigens; Bone Neoplasms; Cathepsins; Dipeptides; Drug Design; Epoxy Compounds; Humans; Lysosomes; Osteoporosis; Propionates; Protein Conformation; Pyridines; Pyridoxine; Receptor, Insulin; Sjogren's Syndrome

2009